Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDO.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 17, 2025
Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: October 12, 2025
Decoding liver injury in cystic fibrosis: How to tell drug-induced liver injury from cystic fibrosis liver disease.
Journal: World journal of gastroenterology
Published: October 11, 2025
Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH study.
Journal: Journal of pediatric gastroenterology and nutrition
Published: August 06, 2025
The Impact of Elexacaftor-Tezacaftor-Ivacaftor on Biochemical Surrogates of Cystic Fibrosis Hepatobiliary Involvement: A Retrospective Cohort Study.
Journal: Pediatric pulmonology
Published: July 09, 2025
Contemporary outcomes of isolated liver and combined liver-lung transplantation for cystic fibrosis in children.
Journal: Journal of pediatric gastroenterology and nutrition
Published: January 24, 2025
Glycemia and Insulin Secretion in Cystic Fibrosis 2 Years After Elexacaftor/Tezacaftor/Ivacaftor: PROMISE-ENDO.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 30, 2024
Understanding advanced cystic fibrosis liver disease through genetic variation: Where do the pathways lead and how much further must we go?
Journal: Hepatology (Baltimore, Md.)
Published: April 09, 2024
Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: December 03, 2023
Cystic fibrosis liver disease in the post-modulator era.
Journal: Current opinion in pulmonary medicine
Published: September 07, 2023
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.
Journal: Hepatology (Baltimore, Md.)
Published: September 06, 2023
Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Children and Adolescents: Current Evidence.
Journal: Therapeutics and clinical risk management
Published: August 15, 2023
Last Updated: 09/26/2026